Immunohistochemical detection of p53 protein and prognosis of surgically resected non-small-cell lung cancer

被引：0

作者：

Quantin, X ^{[1
]}

Pujol, JL ^{[1
]}

Lehmann, M ^{[1
]}

Simony, J ^{[1
]}

Serre, I ^{[1
]}

Michel, FB ^{[1
]}

机构：

[1] UNIV HOSP MONTPELLIER, CHEST DEPT, ARNAUD DE VILLENEUVE HOSP, F-34295 MONTPELLIER, FRANCE

来源：

CANCER DETECTION AND PREVENTION | 1997年 / 21卷 / 05期

关键词：

immunohistochemistry; non-small-cell lung cancer; p53; prognosis; surgery;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We analyzed the survival of 89 surgically treated patients presenting non-small-cell lung cancer in regard to the accumulation of p53 protein as detected by indirect immunoperoxidase reactivity of PAb1801 anti-human p53 protein. Although the well-known factors such as stage grouping, tumor status, and nodal status were found to be prognostic determinants, the p53 protein accumulation had no effect on either univariate analysis or multivariate analysis of survival.

引用

页码：418 / 425

页数：8

共 50 条

[21] p53 and bcl-2 protein expression in non-small-cell lung carcinoma
Athanassiadou, P
Dosios, T
Petrakakou, E
Liossi, A
Zerva, C
Athanassiades, P
DIAGNOSTIC CYTOPATHOLOGY, 1998, 19 (04) : 255 - 259
[22] Rare Gene Mutations in Japanese Surgically Resected Non-Small-Cell Lung Cancer Patients
Nishii, Teppei
Yokose, Tomoyuki
Miyagi, Yohei
Daigo, Yataro
Matsuzaki, Tomohiko
Nagata, Masashi
Isaka, Tetsuya
Furumoto, Hideyuki
Ito, Hiroyuki
Manabe, Saki
Murakami, Shuji
Kondo, Tetsuro
Saito, Haruhiro
Yamada, Kouzo
Masuda, Munetaka
Nakayama, Haruhiko
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S705 - S705
[23] Concurrent Chemoradiotherapy for Patients With Postoperative Recurrence of Surgically Resected Non-Small-Cell Lung Cancer
Takenaka, Tomoyoshi
Takenoyama, Mitsuhiro
Toyozawa, Ryo
Inamasu, Eiko
Yoshida, Tsukihisa
Toyokawa, Gouji
Shiraishi, Yoshimasa
Hirai, Fumihiko
Yamaguchi, Masafumi
Seto, Takashi
Ichinose, Yukito
CLINICAL LUNG CANCER, 2015, 16 (01) : 51 - 56
[24] Prognostic evaluation of the expression of p53 and bcl-2 oncoproteins in patients with surgically resected non-small cell lung cancer
Lai, RS
Wang, JS
Hsu, HK
Chang, HC
Lin, CH
Lin, MH
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2002, 32 (10) : 393 - 397
[25] BRAIN METASTASES AS A FIRST SITE OF RECURRENCE IN SURGICALLY RESECTED NON-SMALL-CELL LUNG CANCER
Chang, Won Jin
Choi, Moon Ki
Hong, Jung Yong
Kim, Moonjin
Lee, Su Jin
Park, Silvia
Kim, Sungmin
Lee, Ji Yun
Lim, Sung Hee
Sun, Jong-Mu
Ahn, Jin Seok
Park, Keunchil
Ahn, Myung-Ju
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S926 - S926
[26] Tumor heterogeneity, hypoxia, and immune markers in surgically resected non-small-cell lung cancer
Castello, Angelo
Grizzi, Fabio
Toschi, Luca
Rossi, Sabrina
Rahal, Daoud
Marchesi, Federica
Russo, Carlo
Finocchiaro, Giovanna
Lopci, Egesta
NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (07) : 636 - 644
[27] Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer
M M Borner
P Brousset
B Pfanner-Meyer
M Bacchi
S Vonlanthen
M A Hotz
H J Altermatt
D Schlaifer
J C Reed
D C Betticher
British Journal of Cancer, 1999, 79 : 952 - 958
[28] Prognostic value of immunohistochemical expression of p53, bax, Bcl-2 and Bcl-xL in resected non-small-cell lung cancers
Groeger, AM
Esposito, V
De Luca, A
Cassandro, R
Tonini, G
Ambrogi, V
Baldi, F
Goldfarb, R
Mineo, TC
Baldi, A
Wolner, E
HISTOPATHOLOGY, 2004, 44 (01) : 54 - 63
[29] Treatment of resected non-small-cell lung cancer
Bria, E
Giannarelli, D
Terzoli, E
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (14): : 1523 - 1523
[30] Clinical implications of p53 autoantibodies in the sera of patients with non-small-cell lung cancer
Mitsudomi, T
Suzuki, S
Yatabe, Y
Nishio, M
Kuwabarn, M
Gotoh, K
Hatooka, S
Shinoda, M
Suyama, M
Ogawa, M
Takahashi, T
Ariyoshi, Y
Takahashi, T
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (20): : 1563 - 1568

← 1 2 3 4 5 →